ArticleHeliyon2023

Targeted delivery of oxaliplatin via folate-decorated niosomal nanoparticles potentiates resistance reversion of colon cancer cells.

Siham Abdulzehra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.